Skip to search formSkip to main contentSkip to account menu

CD19 Expressing Cell Count

Known as: CD19 
The determination of the amount of the CD19 expressing cells in a sample.
National Institutes of Health

Related topics

Related topics

3 relations
CDISC SDTM Laboratory Test Terminology by CodeCDISC SDTM Laboratory Test Terminology by NameClinical Data Interchange Standards Consortium Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
TCRαβ CD19 depletion in allogeneic haematopoietic stem cell transplantation performed for Hurler syndrome
TCRαβ CD19 depletion in allogeneic haematopoietic stem cell transplantation performed for Hurler syndrome 
2012
2012
Phase I study cohort evaluating an optimized administration schedule of SAR3419, an anti-CD19 DM4-loaded antibody drug conjugate (ADC), in patients (pts) with CD19 positive relapsed/refractory b-cell…
8057 Background: The recommended dose (RD) of SAR3419 administered intravenously every 3 weeks (q3w) for 6 cycles is 160 mg/m2… 
2012
2012
MEDI-551, a Humanized Monoclonal Anti-CD19, in Adults with Relapsed or Refractory Advanced B-Cell Malignancies: Results From a Phase 1/2 Study
Abstract 3677 Background: MEDI-551 is an affinity-optimized and afucosylated humanized IgG kappa monoclonal antibody directed… 
Review
2011
Review
2011
Use of the CD19 count in a primary care laboratory as a screening method for B-cell chronic lymphoproliferative disorders in asymptomatic patients with lymphocytosis
Abstract Background: Detection of absolute and relative lymphocytosis in otherwise asymptomatic elderly patients is very common… 
2006
2006
Loss of CD19 expression in B‐cell neoplasms
Aims : To investigate whether an antibody against an intracellular epitope can detect CD19 in routine biopsy specimens and thus… 
2006
2006
Immunophenotype characteristics of peripheral blood mononuclear leukocytes of chronic idiopathic urticaria patients.
The pathogenesis of chronic idiopathic urticaria (CIU) is not completely understood although autoimmunity has been proposed. The… 
2005
2005
CD19-Negative Diffuse Large B-Cell Lymphoma Shows High Serum LDH Level and Poor Prognosis.
CD19 is one of the most representative B-cell markers, and is widely used in diagnostic immunophenotyping in diffuse large B-cell… 
2004
2004
Treating two concurrent B-cell and T-cell lymphoid neoplasms with alemtuzumab monotherapy.
1995
1995
Changes in viral expression and cytokine profile induced by a polyantigenic immunomodulator in HIV-infected peripheral blood mononuclear cells.
This is the first time, to our knowledge, that evidence is presented showing that a polyantigenic immunomodulator (PAI), acting… 
Review
1992
Review
1992
Central nervous system involvement in prolymphocytic transformation of chronic lymphocytic leukemia.
Zale P. Bernstein, Roswell Park Cancer Institute, 666 Elm Street, Buffalo, NY 14263 (USA) This is in reference to a report of a… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)